Specific Mutations in the C-terminus Domain of HBV Surface Antigen Significantly Correlate with Low Level of Serum HBV-DNA in Patients with Chronic HBV Infection.
Carmen Mirabelli,Matteo Surdo,Formijn Van Hemert,Zhichao Lian,Romina Salpini,Valeria Cento,Maria Francesca Cortese,Marianna Aragri,Michela Pollicita,Claudia Alteri,Ada Bertoli,Ben Berkhout,Valeria Micheli,Guido Gubertini,Maria Mercedes Santoro,Sara Romano,Michela Visca,Martina Bernassola,Roberta Longo,Giuseppe Maria De Sanctis,Pascal Trimoulet,Hervè Fleury,Nicoletta Marino,Francesco Mazzotta,Giuseppina Cappiello,Alberto Spanò,Cesare Sarrecchia,Jing Maria Zhang,Massimo Andreoni,Mario Angelico,Jens Verheyen,Carlo Federico Perno,Valentina Svicher
DOI: https://doi.org/10.1016/j.jinf.2014.10.015
2014-01-01
Abstract:BACKGROUND:To define HBsAg-mutations correlated with different serum HBV-DNA levels in HBV chronically-infected drug-naive patients. METHODS:This study included 187 patients stratified into the following ranges of serum HBV-DNA:12-2000 IU/ml, 2000-100,000 IU/ml, and >100,000 IU/ml. HBsAg-mutations were associated with HBV-DNA levels by applying a Bayesian-Partitional-Model and Fisher-exact test. Mutant and wild-type HBV genotype-D genomes were expressed in Huh7 cells and HBsAg-production was determined in cell-supernatants at 3 days-post-transfection. RESULTS:Specific HBsAg-mutations (M197T,-S204N-Y206C/H-F220L) were significantly correlated with serum HBV-DNA <2000 IU/ml (posterior-probability>90%, P < 0.05). The presence of Y206C/H and/or F220L was also associated with lower median (IQR) HBsAg-levels and lower median (IQR) transaminases (for HBsAg:250[115-840] IU/ml for Y206C/H and/or F220L versus 4300[640-11,838] IU/ml for wild-type, P = 0.023; for ALT:28[21-40] IU/ml versus 53[34-90] IU/ml, P < 0.001). These mutations were localized in the HBsAg C-terminus, known to be involved in virion and/or HBsAg secretion. The co-occurrence of Y206C + F220L was found significant by cluster-analysis, (P = 0.02). In addition, in an in-vitro model Y206C + F220L determined a 2.8-3.3 fold-reduction of HBsAg-amount released in supernatants compared to single mutants and wt (Y206C + F220L = 5,679 IU/ml; Y206H = 16,305 IU/ml; F220L = 18,368 IU/ml; Y206C = 18,680 IU/ml; wt = 14,280 IU/ml, P < 0.05). CONCLUSIONS:Specific HBsAg-mutations (compartmentalized in the HBsAg C-terminus) correlated with low-serum HBV-DNA and HBsAg-levels. These findings can be important to understand mechanisms underlying low HBV replicative potential including the inactive-carrier state.